TENAX THERAPEUTICS INC (TENX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-06-05
11:41 am
Sale
2026-05-3113GTENAX THERAPEUTICS INC PAR
TENX
T. Rowe Price Associates, Inc.586,990
2.200%
-2,254,124decrease
(-79.34%)
Filing
History
2026-05-20
5:05 pm
Purchase
2026-05-1813GTENAX THERAPEUTICS INC PAR
TENX
Millennium Management LLC1,347,130
5.100%
1,347,130increase
(New Position)
Filing
History
2026-05-15
6:55 pm
Purchase
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
Logos Global Management LP800,000
3.000%
185,000increase
(+30.08%)
Filing
History
2026-05-15
5:26 pm
Purchase
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
Stonepine Capital Management, LLC975,200
3.700%
602,403increase
(+161.59%)
Filing
History
2026-05-15
4:31 pm
Purchase
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
Venrock Healthcare Capital Partners III, L.P.1,955,105
9.900%
1,262,146increase
(+182.14%)
Filing
History
2026-05-15
4:30 pm
Purchase
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
Point72 Asset Management, L.P.533,965
3.100%
110,550increase
(+26.11%)
Filing
History
2026-05-15
4:14 pm
Sale
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
Lind Global Fund II LP202,480
0.780%
-240,000decrease
(-54.24%)
Filing
History
2026-05-15
4:13 pm
Purchase
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
BIOTECHNOLOGY VALUE FUND L P1,908,722
9.990%
1,140,522increase
(+148.47%)
Filing
History
2026-05-15
4:00 pm
Purchase
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
Perceptive Advisors LLC1,447,782
5.500%
878,474increase
(+154.31%)
Filing
History
2026-05-15
10:35 am
Sale
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
Dellora Investments Master Fund LP394,665
2.300%
-6,406decrease
(-1.60%)
Filing
History
2026-05-15
08:38 am
Purchase
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
RTW Investments, LP1,867,630
9.900%
1,216,662increase
(+186.90%)
Filing
History
2026-05-08
6:19 pm
Purchase
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
Integrated Core Strategies (US) LLC533,889
2.100%
220,177increase
(+70.18%)
Filing
History
2026-05-07
11:04 am
Sale
2026-04-3013GTENAX THERAPEUTICS INC PAR
TENX
T. Rowe Price Associates, Inc.2,841,114
11.000%
-110,002decrease
(-3.73%)
Filing
History
2026-05-07
10:31 am
Sale
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
T. Rowe Price Associates, Inc.2,951,116
17.200%
-798,884decrease
(-21.30%)
Filing
History
2026-05-04
2:46 pm
Unchanged
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
Invus Global Management, LLC427,141
2.500%
0
(Unchanged)
Filing
History
2026-04-08
6:26 pm
Purchase
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
Morgan Stanley
MS
596,564
3.500%
188increase
(+0.03%)
Filing
History
2026-04-07
9:34 pm
Purchase
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
Ikarian Capital, LLC1,145,100
6.700%
177,500increase
(+18.34%)
Filing
History
2026-03-10
6:02 pm
Purchase
2025-12-1013DTENAX THERAPEUTICS INC PAR
TENX
Christopher Thomas Giordano1,252,965
6.790%
1,252,965increase
(New Position)
Filing
History
2026-03-09
12:24 pm
Purchase
2026-02-2713GTENAX THERAPEUTICS INC PAR
TENX
Logos Global Management LP615,000
9.900%
615,000increase
(New Position)
Filing
History
2026-02-17
6:20 pm
Purchase
2025-12-3113GTENAX THERAPEUTICS INC PAR
TENX
Venrock Healthcare Capital Partners III, L.P.692,959
9.900%
139,989increase
(+25.32%)
Filing
History
Goto 0, 1, 2, 3, Next